Amit Hasija
CFO & EVP of Corp. Development · Milestone Pharmaceuticals Inc.
- 2025
- Feb 5, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit Hasija files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joseph Oliveto - $556K in MIST purchases and sales in the last 12 months
- David Bharucha - $158K in MIST purchases and sales in the last 12 months
- Jeffrey Edward Nelson - $158K in MIST purchases and sales in the last 12 months
- Lorenz Muller - $146K in MIST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amit Hasija?
Amit Hasija is a corporate insider, tracked as CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. (MIST). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Amit Hasija last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 4 filings going back to 2025.
Has Amit Hasija been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($158K) across all tracked filings.
